These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25074878)

  • 1. Comorbidity, chemotherapy toxicity, and outcomes among older women receiving adjuvant chemotherapy for breast cancer on a clinical trial: CALGB 49907 and CALGB 361004 (alliance).
    Klepin HD; Pitcher BN; Ballman KV; Kornblith AB; Hurria A; Winer EP; Hudis C; Cohen HJ; Muss HB; Kimmick GG
    J Oncol Pract; 2014 Sep; 10(5):e285-92. PubMed ID: 25074878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104.
    Partridge AH; Archer L; Kornblith AB; Gralow J; Grenier D; Perez E; Wolff AC; Wang X; Kastrissios H; Berry D; Hudis C; Winer E; Muss H
    J Clin Oncol; 2010 May; 28(14):2418-22. PubMed ID: 20368559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.
    Kornblith AB; Lan L; Archer L; Partridge A; Kimmick G; Hudis C; Winer E; Casey R; Bennett S; Cohen HJ; Muss HB
    J Clin Oncol; 2011 Mar; 29(8):1022-8. PubMed ID: 21300923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy in older women with early-stage breast cancer.
    Muss HB; Berry DA; Cirrincione CT; Theodoulou M; Mauer AM; Kornblith AB; Partridge AH; Dressler LG; Cohen HJ; Becker HP; Kartcheske PA; Wheeler JD; Perez EA; Wolff AC; Gralow JR; Burstein HJ; Mahmood AA; Magrinat G; Parker BA; Hart RD; Grenier D; Norton L; Hudis CA; Winer EP;
    N Engl J Med; 2009 May; 360(20):2055-65. PubMed ID: 19439741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized Trial of Standard Adjuvant Chemotherapy Regimens Versus Capecitabine in Older Women With Early Breast Cancer: 10-Year Update of the CALGB 49907 Trial.
    Muss HB; Polley MC; Berry DA; Liu H; Cirrincione CT; Theodoulou M; Mauer AM; Kornblith AB; Partridge AH; Dressler LG; Cohen HJ; Kartcheske PA; Perez EA; Wolff AC; Gralow JR; Burstein HJ; Mahmood AA; Sutton LM; Magrinat G; Parker BA; Hart RD; Grenier D; Hurria A; Jatoi A; Norton L; Hudis CA; Winer EP; Carey L
    J Clin Oncol; 2019 Sep; 37(26):2338-2348. PubMed ID: 31339827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after adding capecitabine and trastuzumab to neoadjuvant anthracycline-taxane-based chemotherapy for primary breast cancer (GBG 40--GeparQuattro).
    von Minckwitz G; Rezai M; Fasching PA; Huober J; Tesch H; Bauerfeind I; Hilfrich J; Eidtmann H; Gerber B; Hanusch C; Blohmer JU; Costa SD; Jackisch C; Paepke S; Schneeweiss A; Kümmel S; Denkert C; Mehta K; Loibl S; Untch M
    Ann Oncol; 2014 Jan; 25(1):81-9. PubMed ID: 24273046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907.
    Freedman RA; Pitcher B; Keating NL; Ballman KV; Mandelblatt J; Kornblith AB; Kimmick GG; Hurria A; Winer EP; Hudis CA; Cohen HJ; Muss HB;
    Breast Cancer Res Treat; 2013 Jun; 139(2):607-16. PubMed ID: 23681403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar survival with single-agent capecitabine or taxane in first-line therapy for metastatic breast cancer.
    Kamal AH; Camacho F; Anderson R; Wei W; Balkrishnan R; Kimmick G
    Breast Cancer Res Treat; 2012 Jul; 134(1):371-8. PubMed ID: 22460617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid As Adjuvant Therapy for Stage III Colon Cancer: Final Results of the NO16968 Randomized Controlled Phase III Trial.
    Schmoll HJ; Tabernero J; Maroun J; de Braud F; Price T; Van Cutsem E; Hill M; Hoersch S; Rittweger K; Haller DG
    J Clin Oncol; 2015 Nov; 33(32):3733-40. PubMed ID: 26324362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for older adults with breast cancer: making the standard a standard.
    Pal SK; Mortimer J
    Womens Health (Lond); 2009 Sep; 5(5):481-4. PubMed ID: 19702447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Saarni O; Helle L; Villman K; Nyandoto P; Nilsson G; Leinonen M; Kataja V; Bono P; Lindman H
    Acta Oncol; 2014 Feb; 53(2):186-94. PubMed ID: 23957715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent vs sequential adjuvant chemotherapy and hormone therapy in breast cancer: a multicenter randomized phase III trial.
    Bedognetti D; Sertoli MR; Pronzato P; Del Mastro L; Venturini M; Taveggia P; Zanardi E; Siffredi G; Pastorino S; Queirolo P; Gardin G; Wang E; Monzeglio C; Boccardo F; Bruzzi P
    J Natl Cancer Inst; 2011 Oct; 103(20):1529-39. PubMed ID: 21921285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
    J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of cancer death by comorbidity severity and use of adjuvant chemotherapy among women with locoregional breast cancer.
    Kimmick GG; Li X; Fleming ST; Sabatino SA; Wilson JF; Lipscomb J; Cress R; Bergom C; Anderson RT; Wu XC;
    J Geriatr Oncol; 2018 May; 9(3):214-220. PubMed ID: 29174187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the first tumor response at eight weeks on overall survival in metastatic breast cancer patients treated with first-line combination chemotherapy.
    Suzuki C; Blomqvist L; Hatschek T; Carlsson L; Einbeigi Z; Linderholm B; Lindh B; Loman N; Malmberg M; Rotstein S; Söderberg M; Sundqvist M; Walz TM; Aström G; Fujii H; Jacobsson H; Glimelius B
    Med Oncol; 2013 Mar; 30(1):415. PubMed ID: 23322522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First efficacy results of capecitabine with anthracycline- and taxane-based adjuvant therapy in high-risk early breast cancer: a meta-analysis.
    Jiang Y; Yin W; Zhou L; Yan T; Zhou Q; Du Y; Shen Z; Shao Z; Lu J
    PLoS One; 2012; 7(3):e32474. PubMed ID: 22396769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. German adjuvant intergroup node-positive study: a phase III trial to compare oral ibandronate versus observation in patients with high-risk early breast cancer.
    von Minckwitz G; Möbus V; Schneeweiss A; Huober J; Thomssen C; Untch M; Jackisch C; Diel IJ; Elling D; Conrad B; Kreienberg R; Müller V; Lück HJ; Bauerfeind I; Clemens M; Schmidt M; Noeding S; Forstbauer H; Barinoff J; Belau A; Nekljudova V; Harbeck N; Loibl S
    J Clin Oncol; 2013 Oct; 31(28):3531-9. PubMed ID: 23980081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of capecitabine monotherapy as the first-line treatment of metastatic HER2-negative breast cancer.
    Babacan T; Efe O; Hasirci AS; Demirci F; Buyukhatipoglu H; Balakan O; Sarici F; Kertmen N; Esin E; Akin S; Ates O; Aksoy S; Sever AR; Altundag K
    Tumori; 2015; 101(4):418-23. PubMed ID: 25953439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance capecitabine and bevacizumab versus bevacizumab alone after initial first-line bevacizumab and docetaxel for patients with HER2-negative metastatic breast cancer (IMELDA): a randomised, open-label, phase 3 trial.
    Gligorov J; Doval D; Bines J; Alba E; Cortes P; Pierga JY; Gupta V; Costa R; Srock S; de Ducla S; Freudensprung U; Mustacchi G
    Lancet Oncol; 2014 Nov; 15(12):1351-60. PubMed ID: 25273343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Older-Patient-Specific Cancer Trials: A Pooled Analysis of 2,277 Patients (A151715).
    Dao D; Zemla T; Jatoi A; Freedman RA; Hurria A; Muss H; Cohen HJ; Shulman LN; Citron M; Budman D; McMurray R; Partridge A; Carey L; Sedrak MS; Lafky JM; Le-Rademacher JG
    Oncologist; 2019 Jun; 24(6):e284-e291. PubMed ID: 30975921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.